Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Downgrade
CRH downgraded to Equal Weight from Overweight at Morgan Stanley » 06:32
06/14/21
06/14
06:32
06/14/21
06:32
CRH

CRH

$52.58 /

+0.45 (+0.86%)

Morgan Stanley analyst…

Morgan Stanley analyst Cedar Ekblom downgraded CRH to Equal Weight from Overweight with a price target of EUR 45, up from EUR 42. The analyst remains bullish on heavy-side but sees more upside in cement versus aggregates. Ekblom still sees value in Holcim and Heidelberg but thinks CRH's risk/reward is more balanced.

ShowHide Related Items >><<
CRH CRH
$52.58 /

+0.45 (+0.86%)

06/10/21 Deutsche Bank
CRH price target raised to EUR 50 from EUR 40 at Deutsche Bank
06/10/21 Deutsche Bank
CRH price target raised to EUR 50 from EUR 40 at Deutsche Bank
05/19/21 Berenberg
CRH price target raised to EUR 40 from EUR 38 at Berenberg
05/12/21 Citi
CRH upgraded to Buy from Neutral at Citi
CRH CRH
$52.58 /

+0.45 (+0.86%)

CRH CRH
$52.58 /

+0.45 (+0.86%)

Recommendations
CRH price target raised to EUR 50 from EUR 40 at Deutsche Bank » 11:46
06/10/21
06/10
11:46
06/10/21
11:46
CRH

CRH

$52.22 /

+0.33 (+0.64%)

Deutsche Bank analyst…

Deutsche Bank analyst Matthias Pfeifenberger raised the firm's price target on CRH to EUR 50 from EUR 40 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
CRH CRH
$52.22 /

+0.33 (+0.64%)

06/10/21 Deutsche Bank
CRH price target raised to EUR 50 from EUR 40 at Deutsche Bank
05/19/21 Berenberg
CRH price target raised to EUR 40 from EUR 38 at Berenberg
05/12/21 Citi
CRH upgraded to Buy from Neutral at Citi
05/12/21 Citi
CRH upgraded to Buy from Neutral at Citi
CRH CRH
$52.22 /

+0.33 (+0.64%)

CRH CRH
$52.22 /

+0.33 (+0.64%)

Recommendations
CRH price target raised to EUR 50 from EUR 40 at Deutsche Bank » 06:38
06/10/21
06/10
06:38
06/10/21
06:38
CRH

CRH

$51.89 /

-1.2 (-2.26%)

Deutsche Bank analyst…

Deutsche Bank analyst Matthias Pfeifenberger raised the firm's price target on CRH to EUR 50 from EUR 40 and reiterates a Buy rating on the shares. The analyst sees "more upside catalysts" for the heavyside/large-cap building materials universe.

ShowHide Related Items >><<
CRH CRH
$51.89 /

-1.2 (-2.26%)

05/19/21 Berenberg
CRH price target raised to EUR 40 from EUR 38 at Berenberg
05/12/21 Citi
CRH upgraded to Buy from Neutral at Citi
05/12/21 Citi
CRH upgraded to Buy from Neutral at Citi
04/30/21 UBS
CRH price target raised to 3,775 GBp from 3,600 GBp at UBS
CRH CRH
$51.89 /

-1.2 (-2.26%)

CRH CRH
$51.89 /

-1.2 (-2.26%)

Over a month ago
Recommendations
CRH price target raised to EUR 40 from EUR 38 at Berenberg » 14:22
05/19/21
05/19
14:22
05/19/21
14:22
CRH

CRH

$50.34 /

-0.74 (-1.45%)

Berenberg analyst Harry…

Berenberg analyst Harry Goad raised the firm's price target on CRH to EUR 40 from EUR 38 and keeps a Hold rating on the shares.

ShowHide Related Items >><<
CRH CRH
$50.34 /

-0.74 (-1.45%)

05/12/21 Citi
CRH upgraded to Buy from Neutral at Citi
05/12/21 Citi
CRH upgraded to Buy from Neutral at Citi
04/30/21 UBS
CRH price target raised to 3,775 GBp from 3,600 GBp at UBS
04/29/21 JPMorgan
CRH price target raised to EUR 47 from EUR 46 at JPMorgan
CRH CRH
$50.34 /

-0.74 (-1.45%)

CRH CRH
$50.34 /

-0.74 (-1.45%)

Upgrade
CRH upgraded to Buy from Neutral at Citi » 06:27
05/12/21
05/12
06:27
05/12/21
06:27
CRH

CRH

$50.25 /

-0.31 (-0.61%)

Citi analyst Ephrem Ravi…

Citi analyst Ephrem Ravi upgraded CRH to Buy from Neutral with a price target of EUR 50, up from EUR 44. CRH has the largest exposure to the U.S. infrastructure market within Europe building products and is best positioned to benefit from growth in that market, Ravi tells investors in a research note.

ShowHide Related Items >><<
CRH CRH
$50.25 /

-0.31 (-0.61%)

05/12/21 Citi
CRH upgraded to Buy from Neutral at Citi
04/30/21 UBS
CRH price target raised to 3,775 GBp from 3,600 GBp at UBS
04/29/21 JPMorgan
CRH price target raised to EUR 47 from EUR 46 at JPMorgan
03/26/21 Morgan Stanley
CRH price target raised to EUR 42 from EUR 41 at Morgan Stanley
CRH CRH
$50.25 /

-0.31 (-0.61%)

CRH CRH
$50.25 /

-0.31 (-0.61%)

Upgrade
CRH upgraded to Buy from Neutral at Citi » 06:17
05/12/21
05/12
06:17
05/12/21
06:17
CRH

CRH

$50.25 /

-0.31 (-0.61%)

Citi analyst Ephrem Ravi…

Citi analyst Ephrem Ravi upgraded CRH to Buy from Neutral.

ShowHide Related Items >><<
CRH CRH
$50.25 /

-0.31 (-0.61%)

04/30/21 UBS
CRH price target raised to 3,775 GBp from 3,600 GBp at UBS
04/29/21 JPMorgan
CRH price target raised to EUR 47 from EUR 46 at JPMorgan
03/26/21 Morgan Stanley
CRH price target raised to EUR 42 from EUR 41 at Morgan Stanley
03/10/21 JPMorgan
CRH price target raised to EUR 46 from EUR 43 at JPMorgan
CRH CRH
$50.25 /

-0.31 (-0.61%)

CRH CRH
$50.25 /

-0.31 (-0.61%)

Recommendations
CRH price target raised to 3,775 GBp from 3,600 GBp at UBS » 12:51
04/30/21
04/30
12:51
04/30/21
12:51
CRH

CRH

$47.33 /

-0.85 (-1.76%)

UBS analyst Gregor…

UBS analyst Gregor Kuglitsch raised the firm's price target on CRH to 3,775 GBp from 3,600 GBp and keeps a Buy rating on the shares.

ShowHide Related Items >><<
CRH CRH
$47.33 /

-0.85 (-1.76%)

04/29/21 JPMorgan
CRH price target raised to EUR 47 from EUR 46 at JPMorgan
03/26/21 Morgan Stanley
CRH price target raised to EUR 42 from EUR 41 at Morgan Stanley
03/10/21 JPMorgan
CRH price target raised to EUR 46 from EUR 43 at JPMorgan
03/09/21 Societe Generale
CRH price target raised to 4,000 GBp from 3,900 GBp at Societe Generale
CRH CRH
$47.33 /

-0.85 (-1.76%)

CRH CRH
$47.33 /

-0.85 (-1.76%)

Recommendations
CRH price target raised to EUR 47 from EUR 46 at JPMorgan » 13:20
04/29/21
04/29
13:20
04/29/21
13:20
CRH

CRH

$48.18 /

+0.22 (+0.46%)

JPMorgan analyst Elodie…

JPMorgan analyst Elodie Rall raised the firm's price target on CRH to EUR 47 from EUR 46 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
CRH CRH
$48.18 /

+0.22 (+0.46%)

03/26/21 Morgan Stanley
CRH price target raised to EUR 42 from EUR 41 at Morgan Stanley
03/10/21 JPMorgan
CRH price target raised to EUR 46 from EUR 43 at JPMorgan
03/09/21 Societe Generale
CRH price target raised to 4,000 GBp from 3,900 GBp at Societe Generale
03/08/21 Barclays
CRH price target raised to EUR 38 from EUR 35 at Barclays
CRH CRH
$48.18 /

+0.22 (+0.46%)

CRH CRH
$48.18 /

+0.22 (+0.46%)

Recommendations
CRH price target raised to EUR 42 from EUR 41 at Morgan Stanley » 12:18
03/26/21
03/26
12:18
03/26/21
12:18
CRH

CRH

$45.82 /

+0.29 (+0.64%)

Morgan Stanley analyst…

Morgan Stanley analyst Cedar Ekblom raised the firm's price target on CRH to EUR 42 from EUR 41 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
CRH CRH
$45.82 /

+0.29 (+0.64%)

03/10/21 JPMorgan
CRH price target raised to EUR 46 from EUR 43 at JPMorgan
03/09/21 Societe Generale
CRH price target raised to 4,000 GBp from 3,900 GBp at Societe Generale
03/08/21 Barclays
CRH price target raised to EUR 38 from EUR 35 at Barclays
03/08/21 Berenberg
CRH price target raised to EUR 38 from EUR 36 at Berenberg
CRH CRH
$45.82 /

+0.29 (+0.64%)

CRH CRH
$45.82 /

+0.29 (+0.64%)

Over a quarter ago
On The Fly
Fly Intel: Pre-market Movers » 08:58
03/16/21
03/16
08:58
03/16/21
08:58
FTCV

FinTech Acquisition Corp. V

$10.69 /

+0.19 (+1.81%)

, AZRX

AzurRx BioPharma

$1.54 /

+0.18 (+13.24%)

, ICAD

iCAD

$18.75 /

+0.11 (+0.59%)

, JBL

Jabil

$48.90 /

+0.475 (+0.98%)

, DFH

Dream Finders Homes

$26.74 /

-0.14 (-0.52%)

, DBI

Designer Brands

$15.88 /

+0.525 (+3.42%)

, CRH

CRH

$48.34 /

+0.1 (+0.21%)

, AKRO

Akero Therapeutics

$32.91 /

+0.015 (+0.05%)

, FCEL

FuelCell

$17.07 /

-1.09 (-6.00%)

, CLSK

CleanSpark

$29.40 /

-1.5 (-4.85%)

Check out this morning's…

ShowHide Related Items >><<
JBL Jabil
$48.90 /

+0.475 (+0.98%)

ICAD iCAD
$18.75 /

+0.11 (+0.59%)

FTCV FinTech Acquisition Corp. V
$10.69 /

+0.19 (+1.81%)

FCEL FuelCell
$17.07 /

-1.09 (-6.00%)

DFH Dream Finders Homes
$26.74 /

-0.14 (-0.52%)

DBI Designer Brands
$15.88 /

+0.525 (+3.42%)

CRH CRH
$48.34 /

+0.1 (+0.21%)

CLSK CleanSpark
$29.40 /

-1.5 (-4.85%)

AZRX AzurRx BioPharma
$1.54 /

+0.18 (+13.24%)

AKRO Akero Therapeutics
$32.91 /

+0.015 (+0.05%)

FTCV FinTech Acquisition Corp. V
$10.69 /

+0.19 (+1.81%)

AZRX AzurRx BioPharma
$1.54 /

+0.18 (+13.24%)

02/10/21 H.C. Wainwright
AzurRx BioPharma price target raised to $3.50 from $2 at H.C. Wainwright
01/06/21 Dawson James
AzurRx BioPharma downgraded to Neutral from Buy at Dawson James
ICAD iCAD
$18.75 /

+0.11 (+0.59%)

02/26/21 B. Riley
iCAD price target raised to $23 from $18 at B. Riley Securities
02/25/21 Oppenheimer
iCAD initiated with an Outperform at Oppenheimer
02/25/21 Craig-Hallum
iCAD price target raised to $22 from $15 at Craig-Hallum
02/25/21 Lake Street
iCAD price target raised to $21 from $17 at Lake Street
JBL Jabil
$48.90 /

+0.475 (+0.98%)

12/21/20 Citi
Citi names Dell new to pick for 2021, adds to Focus List
12/18/20 RBC Capital
Jabil price target raised to $44 from $38 at RBC Capital
12/18/20 Citi
Jabil price target raised to $60 from $50 at Citi
12/18/20 JPMorgan
Flex downgraded to Neutral on valuation at JPMorgan
DFH Dream Finders Homes
$26.74 /

-0.14 (-0.52%)

02/18/21 Wedbush
Dream Finders Homes initiated with Neutral at Wedbush on valuation
02/18/21 Wedbush
Dream Finders Homes initiated with a Neutral at Wedbush
02/16/21 BTIG
Dream Finders Homes initiated with a Neutral at BTIG
02/16/21 RBC Capital
Dream Finders Homes initiated with a Sector Perform at RBC Capital
DBI Designer Brands
$15.88 /

+0.525 (+3.42%)

01/21/21 Deutsche Bank
Designer Brands price target raised to $12 from $7 at Deutsche Bank
01/08/21 CL King
Designer Brands named a top pick for 2021 at CL King
11/09/20 UBS
Designer Brands initiated with a Neutral at UBS
11/03/20 Susquehanna
Designer Brands upgraded to Positive from Neutral at Susquehanna
CRH CRH
$48.34 /

+0.1 (+0.21%)

03/10/21 JPMorgan
CRH price target raised to EUR 46 from EUR 43 at JPMorgan
03/09/21 Societe Generale
CRH price target raised to 4,000 GBp from 3,900 GBp at Societe Generale
03/08/21 Barclays
CRH price target raised to EUR 38 from EUR 35 at Barclays
03/08/21 Berenberg
CRH price target raised to EUR 38 from EUR 36 at Berenberg
AKRO Akero Therapeutics
$32.91 /

+0.015 (+0.05%)

02/26/21 Guggenheim
Akero Therapeutics initiated with a Buy at Guggenheim
11/13/20 H.C. Wainwright
Akero Therapeutics price target raised to $64 from $62 at H.C. Wainwright
10/16/20 H.C. Wainwright
Akero's PRIME designation an 'important recognition,' says H.C. Wainwright
09/10/20 Morgan Stanley
Akero Therapeutics initiated with an Overweight at Morgan Stanley
FCEL FuelCell
$17.07 /

-1.09 (-6.00%)

03/05/21 JPMorgan
FuelCell price target lowered to $9 from $10 at JPMorgan
01/22/21 Canaccord
FuelCell price target raised to $15 from $8.50 at Canaccord
01/14/21
Fly Intel: Top five analyst downgrades
01/14/21 JPMorgan
'Richly valued' FuelCell downgraded to Underweight at JPMorgan
CLSK CleanSpark
$29.40 /

-1.5 (-4.85%)

03/10/21 BTIG
CleanSpark initiated with a Buy at BTIG
03/10/21 BTIG
CleanSpark initiated with a Buy at BTIG
02/16/21 H.C. Wainwright
CleanSpark price target raised to $50 from $24 at H.C. Wainwright
12/11/20 H.C. Wainwright
CleanSpark price target raised to $24 from $18 at H.C. Wainwright
JBL Jabil
$48.90 /

+0.475 (+0.98%)

ICAD iCAD
$18.75 /

+0.11 (+0.59%)

FCEL FuelCell
$17.07 /

-1.09 (-6.00%)

DFH Dream Finders Homes
$26.74 /

-0.14 (-0.52%)

DBI Designer Brands
$15.88 /

+0.525 (+3.42%)

CLSK CleanSpark
$29.40 /

-1.5 (-4.85%)

AKRO Akero Therapeutics
$32.91 /

+0.015 (+0.05%)

  • 16
    Mar
  • 03
    Mar
  • 21
    Jan
  • 02
    Dec
  • 07
    Oct
  • 30
    Sep
  • 08
    Jul
FTCV FinTech Acquisition Corp. V
$10.69 /

+0.19 (+1.81%)

FCEL FuelCell
$17.07 /

-1.09 (-6.00%)

CRH CRH
$48.34 /

+0.1 (+0.21%)

CLSK CleanSpark
$29.40 /

-1.5 (-4.85%)

ICAD iCAD
$18.75 /

+0.11 (+0.59%)

FTCV FinTech Acquisition Corp. V
$10.69 /

+0.19 (+1.81%)

FCEL FuelCell
$17.07 /

-1.09 (-6.00%)

DFH Dream Finders Homes
$26.74 /

-0.14 (-0.52%)

DBI Designer Brands
$15.88 /

+0.525 (+3.42%)

CLSK CleanSpark
$29.40 /

-1.5 (-4.85%)

AZRX AzurRx BioPharma
$1.54 /

+0.18 (+13.24%)

AKRO Akero Therapeutics
$32.91 /

+0.015 (+0.05%)

FCEL FuelCell
$17.07 /

-1.09 (-6.00%)

DFH Dream Finders Homes
$26.74 /

-0.14 (-0.52%)

CLSK CleanSpark
$29.40 /

-1.5 (-4.85%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.